Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy

Lung Cancer

Volumn 41, Issue 3, 2003, Pages 363-367

  Savchenko, Marina S ^a   Bazhin, Alexandr V ^a   Shifrina, Olga N ^b   Demoura, Sofia A ^c   Kogan, Eugenia A ^c   Chuchalin, Alexandr G ^b   Philippov, Pavel P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b Research Institute of Pulmonology   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Autoantibody; Cancer associated retinopathy; Non small cell lung carcinoma; Paraneoplastic antigen; Recoverin

Indexed keywords

AUTOANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT ANTIGEN; RECOVERIN;

AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BIOACCUMULATION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETINOPATHY; TISSUE DISTRIBUTION;

EID: 0043068334     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00239-3     Document Type: Article

References (20)

1. Dropcho E.J. Remote neurologic manifestations of cancer. Neurol. Clin. 20:(1):2002;85-122.
2. Inuzuka T. Autoantibodies in paraneoplasic neurological syndrome. Am. J. Med. Sci. 319:(4):2000;217-226.
3. Posner J.B., Dalmau J.O. Paraneoplasic syndromes of the nervous system. Clin. Chem. Lab. Med. 38:(2):2000;117-122.
4. Dizhoor A.M., Nekrasova E.R., Philippov P.P. New 26 kDa protein specific for photoreceptor cells, capable of binding to immobilized delipidated rhodopsin. Biokhimia. 56:(2):1991;225-228.
5. Dizhoor A.M., Ray S., Kumar S., et al. Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science. 251:(4996):1991;915-918.
6. Thirkill C.E., Roth A.M., Keltner J.L. Cancer-associated retinopathy. Arch. Ophtalmol. 105:(3):1987;372-375.
7. Polans A.S., Buczylko J., Crabb J., Palczewcki K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J. Cell. Biol. 112:(5):1991;981-989.
8. Adamus G., Amundson D., MacKay P.G. Long-term persistence of anti-recoverin antibodies in endometrial cancer-associated retinopathy. Arch. Ophtalmol. 116:(2):1998;251-253.
9. Klingele T.G., Burde R.M., Rappazzo J.A., et al. Paraneoplastic retinopathy. J. Clin. Neuroophtalmol. 4:(4):1984;239-245.
10. Eltabbakh G.H., Hoogereland D.L. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol. Oncol. 58:(1):1995;120-123.
11. Salgia R., Hedges T.R., Rizk M., et al. Cancer-associated retinopathy in a patient with non-small cell lung carcinoma. Lung Cancer. 22:(2):1998;149-152.
12. Thirkill C.E., Keltner J.L., Tyler N.K., Roth A.M. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch. Ophtalmol. 111:(7):1993;931-937.
13. Polans A.S., Witkowska D., Haley T.L., et al. Recoverin, a photoreceptor- specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. USA. 92:(20):1995;9176-9180.
14. Thirkill C.E. Lung cancer-induced blindness. Lung cancer. 14:(2-3):1996;253-264.
15. Yamaji Y., Matsubara S., Yamadori I., et al. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy. Int. J. Cancer. 65:(5):1996;671-676.
16. Bazhin A.V., Shifrina O.N., Savchenko M.S., et al. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. Lung Cancer. 34:(1):2001;99-104.
17. Senin I.I., Zargarov A.A., Alekseev A.M., et al. N-Myristoylation of recoverin enhances its efficiency as an inhibitor of rhodopsin kinase. FEBS Lett. 376:(1-2):1995;87-90.
18. Matsubara S., Yamaji Y., Fujita T., et al. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity. Lung Cancer. 14:(2-3):1996;265-271.
19. Drlicek M., Bianchi G., Bogliun G., et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J. Neurol. 244:(2):1997;85-89.
20. Graus F., Dalmau J., Rene R., et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J. Clin. Oncol. 15:(8):1997;2866-2872.